115
|
332
|
5mahA |
Crystal structure of melk in complex with an inhibitor |
113
|
332
|
5m4uA |
Orthorhombic complex structure of human protein kinase ck2 catalytic subunit (isoform ck2alpha') with the inhibitor 4'-carboxy-6,8-chloro- flavonol (flc21) |
103
|
326
|
5mpjA |
1-(2-chloro-[1,1'-biphenyl]-4-yl)-n-methylethanamine |
111
|
325
|
5mo8A |
Crystal structure of ck2alpha with n-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methanesulfonamide bound |
108
|
326
|
5mohA |
Crystal structure of ck2alpha with zt0583 bound. |
80
|
277
|
5m57A |
Nek2 bound to arylaminopurine 6 |
105
|
325
|
5movA |
Crystal structure of ck2alpha with zt0633 bound |
109
|
328
|
5mowA |
Crystal structure of ck2alpha with zt0432 bound |
99
|
333
|
5mafA |
Crystal structure of melk in complex with an inhibitor |
92
|
286
|
5mqvA |
Crystal structure of human casein kinase i delta in complex with 4-(2,5-dimethoxyphenyl)-n-(4-(5-(4-fluorphenyl)-2-(methylthio)-1h-imidazol-4-yl)-pyridin-2-yl)-1-methyl-1h-pyrrole-2-carboxamide |
116
|
325
|
5moeA |
Crystal structure of ck2alpha with n-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methanesulfonamide bound |
109
|
326
|
5mo5A |
Crystal structure of ck2alpha with n-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methanesulfonamide bound |
113
|
325
|
5mo6A |
Crystal structure of ck2alpha with n-(3-(((2-chloro-[1,1'-biphenyl]-4-yl)methyl)amino)propyl)methanesulfonamide bound |
115
|
325
|
5mp8A |
Crystal structure of ck2alpha with zt0432 bound |
108
|
333
|
5maiA |
Crystal structure of melk in complex with an inhibitor |
115
|
329
|
5m4cA |
Complex structure of human protein kinase ck2 catalytic subunit with a thieno[2,3-d]pyrimidin inhibitor crystallized under low-salt conditions |
104
|
328
|
5motA |
Crystal structure of ck2alpha with zt0627 bound |
83
|
294
|
5lpbA |
Crystal structure of the bri1 kinase domain (865-1160) in complex with adp from arabidopsis thaliana |
101
|
329
|
5m44A |
Complex structure of human protein kinase ck2 catalytic subunit with a thieno[2,3-d]pyrimidin inhibitor crystallized under high-salt conditions |
84
|
267
|
5lxmA |
Crystal structure of aurora-a bound to a hydrocarbon-stapled proteomimetic of tpx2 |
82
|
294
|
5lpyA |
Crystal structure of the bri1 kinase domain (865-1160) in complex with atp from arabidopsis thaliana |
74
|
256
|
5m07A |
Crystal structure of mycobacterium tuberculosis pkni kinase domain, c20a mutant |
79
|
295
|
5lpwA |
Crystal structure of the apo-bri1 kinase domain (865-1160) |
85
|
264
|
5l8lA |
Aurora-a kinase domain in complex with vnar-d01 (crystal form 1) |
90
|
272
|
5m53A |
Nek2 bound to arylaminopurine inhibitor 11 |
75
|
255
|
5m06A |
Crystal structure of mycobacterium tuberculosis pkni kinase domain |
83
|
284
|
5lvmA |
Human pdk1 kinase domain in complex with adenine bound to the atp-binding site |
71
|
256
|
5m08A |
Crystal structure of mycobacterium tuberculosis pkni kinase domain, c20a_r136a double mutant |
85
|
285
|
5lvpA |
Human pdk1 kinase domain in complex with an hm-peptide bound to the pif-pocket |
89
|
267
|
5l8kA |
Aurora-a kinase domain in complex with vnar-d01 (crystal form 2) |
68
|
324
|
5lcwS |
Cryo-em structure of the anaphase-promoting complex/cyclosome, in complex with the mitotic checkpoint complex (apc/c-mcc) at 4.2 angstrom resolution |
117
|
330
|
5m4fA |
Complex structure of human protein kinase ck2 catalytic subunit with the inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) crystallized under low-salt conditions |
88
|
284
|
5lvnA |
Human pdk1 kinase domain in complex with adenosine bound to the atp-binding site |
76
|
294
|
5lpvA |
Crystal structure of the bri1 kinase domain (865-1160) in complex with amppnp and mn from arabidopsis thaliana |
88
|
276
|
5m51A |
Nek2 bound to arylaminopurine compound 8 |
70
|
256
|
5m09A |
Crystal structure of mycobacterium tuberculosis pkni kinase domain, c20a_r136n double mutant |
84
|
286
|
5lvoA |
Human pdk1 kinase domain in complex with allosteric compound pse10 bound to the pif-pocket |
57
|
284
|
5lohA |
Kinase domain of human greatwall |
112
|
331
|
5m4iA |
Complex structure of human protein kinase ck2 catalytic subunit with the inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) crystallized under high-salt conditions |
95
|
492
|
5kq5A |
Ampk bound to allosteric activator |
81
|
303
|
5l4qA |
Crystal structure of adaptor protein 2 associated kinase 1 (aak1) in complex with lkb1 (aak1 dual inhibitor) |
98
|
297
|
5kx8A |
Irak4-inhibitor co-structure |
91
|
316
|
5kz8A |
Mark2 complex with 7-[(1s)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one |
197
|
1445
|
5kc2B |
Negative stain structure of vps15/vps34 complex |
86
|
316
|
5kz7A |
Mark2 complex with 7-[(1s)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one |
52
|
283
|
5kkrB |
Ksr2:mek1 complex bound to the small molecule aps-2-79 |
113
|
331
|
5kwhA |
Crystal structure of ck2 |
113
|
331
|
5ku8A |
Crystal structure of ck2 |
125
|
400
|
5kktA |
Rock 1 bound to azaindole thiazole piperazine inhibitor |
103
|
348
|
5kpmA |
Glycogen synthase kinase 3 beta complexed with brd3731 |